There is no recovery without a transformation. This is conveyed by a greater ability to adapt to the demands of daily life and a significant reduction in the behavioural expression of symptoms. This is combined with a positive experience of oneself in the present and a firm belief in the continuity of oneself in the future, over the medium term. Therapeutic apartments are an example of schemes favouring the patient's recovery. This article presents the example of the Foyer Damidot, near Lyon.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.spsy.2016.11.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Implications of Biomaterials for Chronic Wounds.
Mini Rev Med Chem
January 2025
University of Bucharest, Faculty of Biology, DAFAB Department, Splaiul Independentei 91-95, Bucharest, R-050095, Romania.
The use of biomaterials in treating and managing chronic wounds represents a significant challenge in global healthcare due to the complex nature of these wounds, which are slow to heal and can lead to complications such as frequent infections and diminished quality of life for patients. Chronic wounds, which can arise from conditions like diabetes, poor circulation, and pressure sores, pose distinct challenges in wound care, necessitating the development of specialized dressings. The pathophysiology of chronic wounds is thoroughly examined in this article, with particular attention paid to the cellular and molecular defects at work and the therapeutic guidelines.
View Article and Find Full Text PDFUsing a Device-Free Wi-Fi Sensing System to Assess Daily Activities and Mobility in Low-Income Older Adults: Protocol for a Feasibility Study.
JMIR Res Protoc
November 2024
College of Engineering, Virginia Commonwealth University, Richmond, VA, United States.
Background: Older adults belonging to racial or ethnic minorities with low socioeconomic status are at an elevated risk of developing dementia, but resources for assessing functional decline and detecting cognitive impairment are limited. Cognitive impairment affects the ability to perform daily activities and mobility behaviors. Traditional assessment methods have drawbacks, so smart home technologies (SmHT) have emerged to offer objective, high-frequency, and remote monitoring.
View Article and Find Full Text PDFBiologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis.
Immunol Allergy Clin North Am
November 2024
Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room B1-28, 4 Memorial Drive, Bethesda, MD 20892, USA. Electronic address:
Article Synopsis
- Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) are disorders characterized by high levels of eosinophils in the blood and tissues, leading to varied symptoms.
- Traditionally, treatment has relied on systemic glucocorticoids; however, new biologic therapies targeting eosinophils offer alternatives that could lead to better results with fewer side effects.
- The article reviews the evidence for using these biologics in treating HES and EGPA and outlines how they can be effectively employed in patient care.
Advancements in Biologic Therapies for Eosinophilic Gastrointestinal Diseases: A Comprehensive Review.
Immunol Allergy Clin North Am
November 2024
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, ML7028, Cincinnati, OH 45229, USA. Electronic address:
Article Synopsis
- Eosinophilic gastrointestinal diseases (EGIDs) are disorders marked by an excess of eosinophils in the GI tract, causing symptoms like abdominal pain and difficulty swallowing.
- Effective treatments are being developed, focusing on monoclonal antibodies that target inflammatory responses related to eosinophils.
- Dupilumab is the only FDA-approved monoclonal antibody for treating eosinophilic esophagitis (EoE), and the article will explore various biologics used for managing EGIDs.
Effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy among cancer survivors in Japan: a retrospective study.
BMC Cancer
August 2024
Department of Medical Oncology, Kanazawa Medical University Hospital, 1-1 Uchinada, Kahoku, 920-0293, Ishikawa, Japan.
Background: The study aim was to elucidate the effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy treatment of cancer survivors at Kanazawa Medical University Hospital (KMUH), Japan.
Methods: Medical and nursing records for January 4-31, 2024, from KMUH were retrospectively collected, and data for 286 participants were analyzed.
Results: Of the 286 participants, 95.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!